LINKÖPING, Sweden; November 28, 2020 – AMRA’s abstracts have been showcased at the Best of The Liver Meeting® for two years in a row. AMRA is honoured by the high regard for our research by the American Association for the Study of Liver Diseases (AASLD) review committee.
AMRA Medical researchers presented new data at The Liver Meeting Digital Experience® 2020 revealing the impact of discordant body fat distribution on coronary heart disease (CHD) risk. In collaboration with Dr. Ian Neeland at University Hospitals, AMRA researchers found an increased risk of coronary events among people with high visceral adipose tissue and low liver fat.
The abstract titled “Can Low Liver Fat Be Bad For Your Heart? The High Visceral Fat, Low Liver Fat Phenotype – A Risk Factor For Coronary Heart Disease” was presented by AMRA’s Lead Scientist Jennifer Linge, and was included in the NAFLD and NASH category of the Best of The Liver Meeting®. Later, the NAFLD/NASH slide deck became available on the AASLD’s LiverLearning website.
During The Liver Meeting 2020 on demand NAFLD debrief session, Dr. Naga Chalasani referenced AMRA’s abstract. He noted the results that visceral fat stratifies individuals at risk for coronary heart disease; and that among those with high visceral fat, if you have low liver fat this seems to be the highest risk group for coronary events.
AMRA’s researchers are looking forward to researching the topic further. Dr. Chalasani is considered an authority in the fields of Non-Alcoholic Fatty Liver Disease (NAFLD) and Drug Induced Liver Injury (DILI).
To view the full presentation click here.
